CD8A and neoplasm: Although various strategies have been developed to enhance tumor immunogenicity, a notable deficiency is the lack of infiltration by CD8+ T cells or dendritic cells (DCs), which undermines the efficacy of immunotherapy (Hanoteau et al., 2019; Trujillo et al., 2019).